Literature DB >> 26840096

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Stephen T Bartlett1, James F Markmann, Paul Johnson, Olle Korsgren, Bernhard J Hering, David Scharp, Thomas W H Kay, Jonathan Bromberg, Jon S Odorico, Gordon C Weir, Nancy Bridges, Raja Kandaswamy, Peter Stock, Peter Friend, Mitsukazu Gotoh, David K C Cooper, Chung-Gyu Park, Phillip OʼConnell, Cherie Stabler, Shinichi Matsumoto, Barbara Ludwig, Pratik Choudhary, Boris Kovatchev, Michael R Rickels, Megan Sykes, Kathryn Wood, Kristy Kraemer, Albert Hwa, Edward Stanley, Camillo Ricordi, Mark Zimmerman, Julia Greenstein, Eduard Montanya, Timo Otonkoski.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26840096      PMCID: PMC4741413          DOI: 10.1097/TP.0000000000001055

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  368 in total

Review 1.  Continuous glucose monitoring: roadmap for 21st century diabetes therapy.

Authors:  David C Klonoff
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

2.  Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up.

Authors:  P A Gerber; V Pavlicek; N Demartines; R Zuellig; T Pfammatter; R Wüthrich; M Weber; G A Spinas; R Lehmann
Journal:  Diabetologia       Date:  2007-11-01       Impact factor: 10.122

3.  Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.

Authors:  Z A Stewart; B E Lonze; D S Warren; N N Dagher; A L Singer; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2009-03-03       Impact factor: 8.086

4.  Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.

Authors:  Klemens Budde; Thomas Rath; Claudia Sommerer; Hermann Haller; Petra Reinke; Oliver Witzke; Barbara Suwelack; Daniel Baeumer; Christoph May; Martina Porstner; Wolfgang Arns
Journal:  Clin Nephrol       Date:  2015-01       Impact factor: 0.975

5.  Insulin resistance compensation: not just a matter of β-Cells?

Authors:  Eduard Montanya
Journal:  Diabetes       Date:  2014-03       Impact factor: 9.461

6.  Beta-cell failure, stress, and type 2 diabetes.

Authors:  Randal J Kaufman
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

7.  Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Authors:  Garry M Steil; Kerstin Rebrin; Christine Darwin; Farzam Hariri; Mohammed F Saad
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

8.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.

Authors:  Joachim Denner; Henk-Jan Schuurman; Clive Patience
Journal:  Xenotransplantation       Date:  2009 Jul-Aug       Impact factor: 3.907

9.  Immunoprotection of rat islet xenografts by cotransplantation with sertoli cells and a single injection of antilymphocyte serum.

Authors:  Jannette M Dufour; Ray V Rajotte; Tatsuya Kin; Gregory S Korbutt
Journal:  Transplantation       Date:  2003-05-15       Impact factor: 4.939

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  16 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 2.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 3.  The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds.

Authors:  James D Johnson
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

Review 4.  Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.

Authors:  Michael R Rickels; Peter G Stock; Eelco J P de Koning; Lorenzo Piemonti; Johann Pratschke; Rodolfo Alejandro; Melena D Bellin; Thierry Berney; Pratik Choudhary; Paul R Johnson; Raja Kandaswamy; Thomas W H Kay; Bart Keymeulen; Yogish C Kudva; Esther Latres; Robert M Langer; Roger Lehmann; Barbara Ludwig; James F Markmann; Marjana Marinac; Jon S Odorico; François Pattou; Peter A Senior; James A M Shaw; Marie-Christine Vantyghem; Steven White
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

Review 5.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

6.  Islet cell transplant: Update on current clinical trials.

Authors:  Christian Schuetz; James F Markmann
Journal:  Curr Transplant Rep       Date:  2016-05-17

7.  Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.

Authors:  Bernhard J Hering; William R Clarke; Nancy D Bridges; Thomas L Eggerman; Rodolfo Alejandro; Melena D Bellin; Kathryn Chaloner; Christine W Czarniecki; Julia S Goldstein; Lawrence G Hunsicker; Dixon B Kaufman; Olle Korsgren; Christian P Larsen; Xunrong Luo; James F Markmann; Ali Naji; Jose Oberholzer; Andrew M Posselt; Michael R Rickels; Camillo Ricordi; Mark A Robien; Peter A Senior; A M James Shapiro; Peter G Stock; Nicole A Turgeon
Journal:  Diabetes Care       Date:  2016-04-18       Impact factor: 19.112

Review 8.  Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.

Authors:  Michael R Rickels; Peter G Stock; Eelco J P de Koning; Lorenzo Piemonti; Johann Pratschke; Rodolfo Alejandro; Melena D Bellin; Thierry Berney; Pratik Choudhary; Paul R Johnson; Raja Kandaswamy; Thomas W H Kay; Bart Keymeulen; Yogish C Kudva; Esther Latres; Robert M Langer; Roger Lehmann; Barbara Ludwig; James F Markmann; Marjana Marinac; Jon S Odorico; François Pattou; Peter A Senior; James A M Shaw; Marie-Christine Vantyghem; Steven White
Journal:  Transpl Int       Date:  2018-04       Impact factor: 3.782

9.  Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes.

Authors:  Barbara Ludwig; Stefan Ludwig; Anja Steffen; Yvonne Knauf; Baruch Zimerman; Sophie Heinke; Susann Lehmann; Undine Schubert; Janine Schmid; Martina Bleyer; Uwe Schönmann; Clark K Colton; Ezio Bonifacio; Michele Solimena; Andreas Reichel; Andrew V Schally; Avi Rotem; Uriel Barkai; Helena Grinberg-Rashi; Franz-Josef Kaup; Yuval Avni; Peter Jones; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

Review 10.  Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic?

Authors:  Elisabeth Kemter; Joachim Denner; Eckhard Wolf
Journal:  Curr Diab Rep       Date:  2018-09-18       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.